CVE-2022-4594

drogatkin TJWS2 WarRoller.java deployWar path traversal

Description

A vulnerability was found in drogatkin TJWS2. It has been declared as critical. Affected by this vulnerability is the function deployWar of the file 1.x/src/rogatkin/web/WarRoller.java. The manipulation leads to path traversal. The attack can be launched remotely. The name of the patch is 1bac15c496ec54efe21ad7fab4e17633778582fc. It is recommended to apply a patch to fix this issue. The associated identifier of this vulnerability is VDB-216187.

Category

6.3
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.07%
Third-Party Advisory github.com Third-Party Advisory vuldb.com
Affected: drogatkin TJWS2
Published at:
Updated at:

References

Link Tags
https://github.com/drogatkin/TJWS2/commit/1bac15c496ec54efe21ad7fab4e17633778582fc third party advisory patch
https://vuldb.com/?id.216187 third party advisory permissions required

Frequently Asked Questions

What is the severity of CVE-2022-4594?
CVE-2022-4594 has been scored as a medium severity vulnerability.
How to fix CVE-2022-4594?
To fix CVE-2022-4594, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2022-4594 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2022-4594 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-4594?
CVE-2022-4594 affects drogatkin TJWS2.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.